Coherent introduces pin-hole array biochips for medical diagnostics

Pittsburgh, jan. 22, 2025 (globe newswire) -- coherent corp. (nyse: cohr), a global leader in laser and photonic solutions, today announces the launch of new pin-hole array biochips for medical diagnostics, with a focus on gene sequencing applications. developed by the coherent advanced optics team, this groundbreaking approach consolidates the entire production process, addressing key challenges in cost, efficiency, and supply chain management for professionals in the diagnostic field.
COHR Ratings Summary
COHR Quant Ranking